Unilabs News | Unilabs

Unilabs News

Our News section features the latest updates from our team including press releases and expert blogs from leading medical professionals, offering in-depth analysis and advice in diagnostic medicine. Explore the diagnostics that are shaping the future of healthcare. For media enquiries, please contact our press office.

Media Release
19 December 2017
Unilabs announces an organisational management change
Given the fast growing size of the company and the increasing number of countries where it operates, Unilabs has resized the management structure into a smaller Unilabs Management Team (UMT), effective from 1st January 2018.
Featured News
13 November 2017
Unilabs acquires Telemedicine Clinic, a leading European Provider of teleradiology and telepathology services
Unilabs is pleased to announce the acquisition of Telemedicine Clinic (“TMC”), a leading European provider of teleradiology and telepathology services.
Media Release
6 October 2017
Unilabs announces pricing of its upsized tap senior notes offering, upsize of its term loan syndication
Unilabs SubHolding AB (publ) today announced that it has priced its offering of €155 million aggregate principal amount of its existing 5.75% senior notes due 2025 (the “Notes”).
Featured News
3 October 2017
Unilabs announces launch of tap Senior notes Offering
Unilabs SubHolding AB (publ) (the “Issuer”) today announced the offering of €130,000,000 aggregate principal amount of its existing 5.75% senior notes due 2025 (the “Notes”).
Media Release
14 September 2017
Philipp Manser steps down as Unilabs CFO. Previous CFO Karl Erik Clausen rejoins on an interim basis
European medical diagnostics leader Unilabs announces today that Philipp Manser, the company’s CFO, has resigned for personal reasons.
Media Release
30 August 2017
Unilabs marks 12 consecutive quarters of growth
Unilabs, Europe’s leading provider of clinical laboratory testing and medical diagnostic imaging services, reports a solid Q2 2017, delivering the 12th consecutive quarter of EBITDA growth.
Featured News
7 August 2017
Unilabs to acquire Blufstein, one of the largest independent and accredited laboratories in Peru
Unilabs announced today an agreement to acquire Blufstein, one of the top 3 accredited and private laboratories in Peru, for an undisclosed amount.
Media Release
27 July 2017
Unilabs to acquire Scientific Clinical Laboratories
Unilabs today announced it has signed a definitive agreement to acquire a share of Scientific Clinical Laboratories (SCL) for an undisclosed amount. Established in 1990, SCL has been providing highly-specialised laboratory services in the UAE, with a strong brand recognition and a leading market position.
Media Release
19 July 2017
Unilabs to acquire Base Holding, a leading Portuguese Diagnostic Services company
Unilabs has today signed definitive agreement to acquire Base Holding, a leading diagnostic company in Portugal, which services customers in clinical analysis, radiology and cardiology. With this acquisition, Unilabs expands its portfolio of diagnostic services in Portugal to radiology and extends its presence in the country.
Media Release
20 June 2017
Unilabs acquires CGC Genetics, a leading Medical Genetics Laboratory company in Portugal
Geneva, Porto 19th June 2017. Geneva based Unilabs today announced that it has reached an agreement to acquire CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount from private equity firm Vallis Capital Partners.
Media Release
20 May 2017
Unilabs subholding announces pricing of its senior notes offering
Unilabs SubHolding AB (publ) (the “Issuer”) today announced that it has priced its offering of €250,000,000 aggregate principal amount of 5.75% senior notes due 2025 (the “Notes”). The offering is expected to close on May 5, 2017.
Media Release
16 May 2017
Q1 2017 Results - With a particularly strong start to 2017, Unilabs delivers the 11th consecutive quarter of organic EBITDA growth
European medical diagnostics leader Unilabs reports a strong start into to 2017, delivering the 11th consecutive quarter of EBITDA growth. Commenting on the results, Jos Lamers, Chief Executive Officer stated, “What makes this quarter particularly noteworthy is that we have generated strong growth across both our Lab and Imaging segments as well as our various regions. This is also our 11th consecutive quarter delivering a sustainable organic EBITDA growth.”